SurgePays (SURG) Projected to Release Earnings on Wednesday

SurgePays (NASDAQ:SURG) is expected to release its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect the company to post earnings of ($0.11) per share and revenue of $13.80 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 12, 2026 at 5:00 PM ET.

SurgePays (NASDAQ:SURG) last issued its earnings results on Wednesday, May 20th. The medical equipment provider reported ($0.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.32). The business had revenue of $15.98 million during the quarter, compared to analyst estimates of $15.49 million. On average, analysts expect SurgePays to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

SurgePays Trading Down 1.2%

SurgePays stock opened at $0.21 on Wednesday. The stock has a 50-day moving average price of $0.39 and a two-hundred day moving average price of $0.68. SurgePays has a 12 month low of $0.20 and a 12 month high of $3.22. The company has a market capitalization of $5.28 million, a PE ratio of -0.11 and a beta of 0.42.

Hedge Funds Weigh In On SurgePays

A number of hedge funds have recently bought and sold shares of the company. Jones Financial Companies Lllp boosted its position in SurgePays by 34,091.3% during the first quarter. Jones Financial Companies Lllp now owns 51,287 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 51,137 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in shares of SurgePays in the 1st quarter worth about $28,000. Cetera Investment Advisers lifted its stake in SurgePays by 61.0% in the second quarter. Cetera Investment Advisers now owns 45,400 shares of the medical equipment provider’s stock valued at $141,000 after buying an additional 17,200 shares during the period. XTX Topco Ltd acquired a new position in shares of SurgePays during the second quarter worth approximately $125,000. Finally, NewEdge Advisors LLC increased its stake in SurgePays by 46.2% during the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 6,000 shares in the last quarter. Institutional investors own 6.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Ascendiant Capital Markets dropped their price objective on shares of SurgePays from $5.00 to $3.50 and set a “buy” rating for the company in a report on Wednesday, June 10th. Weiss Ratings restated a “sell (e+)” rating on shares of SurgePays in a research report on Friday, May 22nd. Finally, Zacks Research downgraded shares of SurgePays from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One analyst has rated the stock with a Buy rating and two have given a Sell rating to the stock. According to MarketBeat, SurgePays currently has a consensus rating of “Reduce” and a consensus target price of $3.50.

About SurgePays

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.